|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 10, 2017 ) The Europe Viral Inactivation Market was worth USD 95 million in 2016 and estimated to be growing at a CAGR of 12.1%, to reach USD 170 million by 2021. Viral Inactivation is the method by which viral cells are killed or made inactive. It is done in order to enhance the safety and to prevent contamination of products by viruses. If the viruses are present in the final product, they are in inactive form. All the inactivation techniques are done primarily in blood plasma and food industries to protect the products from viruses.
View full report @ http://www.marketdataforecast.com/market-reports/europe-viral-inactivation-market-3231/
Among the many methods in which Viral Inactivation is done, some of them are , irradiation by UV rays, dry heating, pasteurization, solvent/detergent usage and lowering the pH among others. Pasteurization is useful only if the proteins to be protected have more thermal resistance than the viruses to be killed. UV radiations achieves the ends by creating nucleic acid dimers, thus affecting life cycle and reproduction processes of viruses. Viral Inactivation by solvents and detergents is the most commonly used method in the blood plasma industry, but it is effective only for viruses encapsulated in lipid molecules. The detergents/solvents interacts with the lipid layers in which viruses are present and make them ineffective since they cannot survive without lipid molecules. Lowering pH is effective when the molecules in the product are more resistant than viruses.
The driving factors of Europe Viral Inactivation market are focus of research and development industries in life sciences, high growth in pharmaceuticals and biotechnology industries, launch of new drugs, rising incidence of chronic diseases and growing support of government in biotechnology and pharmaceuticals sectors among others. However, this market is constrained by presence of strong consolidation and less number of skilled workers.
Request sample @ http://www.marketdataforecast.com/market-reports/europe-viral-inactivation-market-3231/request-sample
The Europe Viral Inactivation market is segmented on the basis of method, product, application and end-user. Based on method, the market is segmented into solvent/detergent method, pasteurization, UV radiation, microwave heating and high-energy light. The largest market share is held by solvent/detergent method since it requires less investment, easy to use and it achieves high degree of inactivation of viruses. Based on product the market is divided into services, kits and reagents, accessories and viral inactivation systems. With respect to application, the market is fragmented into vaccines and therapeutics, stem cell products, cell culture, gene therapy and blood & blood products. Vaccines and therapeutics has the largest share in this segment. Based on end-users, the market is segmented into academic institutions, research organisations, pharmaceutical companies and others.
The Europe market for Viral Inactivation is geographically segmented into United Kingdom, Spain, France, Italy and Germany. Europe is the second largest market in the world by share. Factors such as rising support of government in pharmaceuticals and biotechnology sectors and rising incidence of chronic diseases is expected to drive the growth of this market in the forecast period.
Some of the major players in the market include Clean Cells, Charles River Laboratories International Inc, Danaher Corporation, Merck KGaA, Parker Hannifin, Red Source Technologies, Sartorius AG, SGS S.A, Texcell Inc, Viral Inactivated Plasma Systems SA, and WuXi Pharma Tech Inc.
Market Segmentation
1) Method
Solvent/Detergent Method
Pasteurization
UV Radiation
Microwave Heating
High-Energy Light
Y-o-Y Growth Analysis, By Method
Market Attractiveness Analysis, By Method
Market Share Analysis, By Method
2) Product
Kits and Reagents
Services
Accesories
Viral Inactivation Systems
Y-o-Y Growth Analysis, By Product
Market Attractiveness Analysis, By Product
Market Share Analysis, By Product
3) Application
Vaccines and Therapeutics
Stem Cell Products
Cell Culture
Gene Therapy
Blood & Blood Products
Y-o-Y Growth Analysis, By Application
Market Attractiveness Analysis, By Application
Market Share Analysis, By Application
4) End User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Research Institutes
Other End Users
Y-o-Y Growth Analysis, By End User
Market Attractiveness Analysis, By End User
Market Share Analysis, By End User
Inquire before buying@ http://www.marketdataforecast.com/market-reports/europe-viral-inactivation-market-3231/inquire
About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research.
Contact us
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
